Aims & Scope

Aims

Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of Personalized Medicine together on one platform. JPM reports innovative preclinical and translational scientific research, technological advances, and novel clinical medicine applications that advance the study and implementation of Personalized Medicine, publishing research papers, reviews, editorials, communications, etc. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible, with their full experimental details provided so that their results can be reproduced.

We provide a forum that brings together academic and clinical researchers, biotechnologists, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities. By deploying high-quality continuous improvement in all its processes, the Journal of Personalized Medicine seeks to be the most relevant and highest quality journal in its field, and aspires to be amongst the best journals across scholarly publishing.

Scope

For a comprehensive perspective comprising primary research, commentaries, and reviews related to Personalized Medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics, diagnostics, and medical care, as well as discussions of regulatory, social, ethical, and policy aspects. JPM particularly encourages submissions that focus on the following topics within its scope:

• Novel and emerging informatics applied to personalized medicine, including well-grounded artificial intelligence/machine learning-enabled methods.
• Diagnostic characteristics for disease subtypes, or evidence for groups of patients who are likely to respond to therapy vs. those who do not.
• Processes such as organ/tissue transplantation, where de-personalizing donor tissue results in broader positive outcomes for recipients.

Papers that may be considered as out of scope include the following:

• Methods papers that do not describe subpopulations where their approaches might be most or least effective.
• Reports and theoretical studies with broad implications only.

MDPI Publication Ethics Statement

MDPI is a member of the Committee on Publication Ethics (COPE). MDPI takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, inappropriate authorship credit, and the like, do arise. MDPI takes such publishing ethics issues very seriously and our editors are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use iThenticate to check submissions against previous publications.

Book Reviews

Authors and publishers are encouraged to send review copies of their recent related books to the following address. Received books will be listed as Books Received within the journal's News & Announcements section.

MDPI
Grosspeteranlage 5
CH-4052 Basel
Switzerland

Copyright / Open Access

Articles published in JPM will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). The copyright is retained by the author(s). MDPI will insert the following note at the end of the published text:

Reprints

Reprints may be ordered. Please contact publisher@mdpi.com for more information on how to order reprints.

Announcement and Advertisement

Announcements regarding academic activities such as conferences are published for free in the News & Announcements section of the journal. Advertisement can be either published or placed on the pertinent website. Contact e-mail address is jpm@mdpi.com.